MPM BIOVENTURES 2018, L.P. sold TRDA
September 2, 2026 · Form 4 insider transaction
MPM BIOVENTURES 2018, L.P. sold 25,131 shares of Entrada Therapeutics, Inc. at $7.19 per share, a transaction worth $180.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The shares were sold as follows: 11,412 by BV 2014, 761 by BV 2014(B), 393 by AM BV2014, 11,712 by BV 2018, 622 by BV 2018(B) and 231 by AM BV2018.; Price represents the weighted average sale price of the shares sold. The sale price ranged from $6.9601 to $7.3273 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.; Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.; The shares are held as follows: 1,896,805 by BV 2014, 126,513 by BV 2014(B), 65,288 by AM BV2014, 1,946,721 by BV 2018, 103,467 by BV 2018(B) and 38,421 by AM BV2018.